BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jung G, Hernández-Illán E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol 2020;17:111-30. [PMID: 31900466 DOI: 10.1038/s41575-019-0230-y] [Cited by in Crossref: 97] [Cited by in F6Publishing: 112] [Article Influence: 48.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Han T, Wang X, Wang Y, Chen X, Chen W, Yang Q. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Front Genet 2022;13:851373. [DOI: 10.3389/fgene.2022.851373] [Reference Citation Analysis]
2 do Canto LM, Barros-Filho MC, Rainho CA, Marinho D, Kupper BEC, Begnami MDFS, Scapulatempo-Neto C, Havelund BM, Lindebjerg J, Marchi FA, Baumbach J, Aguiar S Jr, Rogatto SR. Comprehensive Analysis of DNA Methylation and Prediction of Response to NeoadjuvantTherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3079. [PMID: 33105711 DOI: 10.3390/cancers12113079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wang L, Wang X, Yan P, Liu Y, Jiang X. LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis. Front Cell Dev Biol 2021;9:687788. [PMID: 34336838 DOI: 10.3389/fcell.2021.687788] [Reference Citation Analysis]
4 Gadwal A, Modi A, Khokhar M, Vishnoi JR, Choudhary R, Elhence P, Banerjee M, Purohit P. Critical appraisal of epigenetic regulation of galectins in cancer. Int J Clin Oncol 2021. [PMID: 34652614 DOI: 10.1007/s10147-021-02048-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Staiteieh SA, Akil L, Al Khansa R, Nasr R, Al Sagheer Z, Houshaymi B, Merhi RA. Study of microRNA expression profiling as biomarkers for colorectal cancer patients in Lebanon. Mol Clin Oncol 2022;16:39. [PMID: 35003737 DOI: 10.3892/mco.2021.2473] [Reference Citation Analysis]
6 Liu F, Chen J, Li Z, Meng X. Recent Advances in Epigenetics of Age-Related Kidney Diseases. Genes 2022;13:796. [DOI: 10.3390/genes13050796] [Reference Citation Analysis]
7 Wang X, Liu J, Wang D, Feng M, Wu X. Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer. Brief Bioinform 2021;22:bbaa309. [PMID: 33300554 DOI: 10.1093/bib/bbaa309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang X, Hong R, Bei L, Yang J, Zhao X, Hu Z, Chen L, Meng H, Zhang Q, Niu G, Yue Y, Ke C. Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway. Translational Oncology 2022;18:101365. [DOI: 10.1016/j.tranon.2022.101365] [Reference Citation Analysis]
9 Abumustafa W, Zamer BA, Khalil BA, Hamad M, Maghazachi AA, Muhammad JS. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies. Biomed Pharmacother 2021;145:112368. [PMID: 34794114 DOI: 10.1016/j.biopha.2021.112368] [Reference Citation Analysis]
10 Maugeri A, Barchitta M, Magnano San Lio R, Li Destri G, Agodi A, Basile G. Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research. Int J Mol Sci 2020;22:E200. [PMID: 33379143 DOI: 10.3390/ijms22010200] [Reference Citation Analysis]
11 Sasidharan Nair V, Saleh R, Toor SM, Taha RZ, Ahmed AA, Kurer MA, Murshed K, Abu Nada M, Elkord E. Epigenetic regulation of immune checkpoints and T cell exhaustion markers in tumor-infiltrating T cells of colorectal cancer patients. Epigenomics 2020;12:1871-82. [PMID: 33169618 DOI: 10.2217/epi-2020-0267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li Y, Wu Y, Hu Y. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications. Front Immunol 2021;12:641883. [PMID: 33927716 DOI: 10.3389/fimmu.2021.641883] [Reference Citation Analysis]
13 Turpín-Sevilla MDC, Pérez-Sanz F, García-Solano J, Sebastián-León P, Trujillo-Santos J, Carbonell P, Estrada E, Tuomisto A, Herruzo I, Fennell LJ, Mäkinen MJ, Rodríguez-Braun E, Whitehall VLJ, Conesa A, Conesa-Zamora P. Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features. Cancers (Basel) 2021;13:5165. [PMID: 34680315 DOI: 10.3390/cancers13205165] [Reference Citation Analysis]
14 Li J, Liang L, Yang Y, Li X, Ma Y. N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction. Theranostics 2021;11:2581-93. [PMID: 33456561 DOI: 10.7150/thno.52366] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
15 Pan X, Hou X, Zhang F, Tang P, Wan W, Su Z, Yang Y, Wei W, Du Z, Deng J, Hao E. Gnetum montanum extract induces apoptosis by inhibiting the activation of AKT in SW480 human colon cancer cells. Pharm Biol 2022;60:915-30. [PMID: 35587342 DOI: 10.1080/13880209.2022.2063340] [Reference Citation Analysis]
16 Farhana A, Koh AE, Ling Mok P, Alsrhani A, Khan YS, Subbiah SK. Camptothecin Encapsulated in β-Cyclodextrin-EDTA-Fe3O4 Nanoparticles Induce Metabolic Reprogramming Repair in HT29 Cancer Cells through Epigenetic Modulation: A Bioinformatics Approach. Nanomaterials (Basel) 2021;11:3163. [PMID: 34947512 DOI: 10.3390/nano11123163] [Reference Citation Analysis]
17 Cao LJ, Peng XL, Xue WQ, Zhang R, Zhang JB, Zhou T, Wu ZY, Li GR, Wang TM, He YQ, Yang DW, Liao Y, Tong XT, Wang F, Chen KX, Zhang SH, Zhu LQ, Ding PR, Jia WH. A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study. BMC Med 2021;19:250. [PMID: 34689777 DOI: 10.1186/s12916-021-02123-0] [Reference Citation Analysis]
18 Li D, Zhang L, Fu J, Huang H, Sun S, Zhang D, Zhao L, Ucheojor Onwuka J, Zhao Y, Cui B. SCTR hypermethylation is a diagnostic biomarker in colorectal cancer. Cancer Sci 2020;111:4558-66. [PMID: 32970347 DOI: 10.1111/cas.14661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Wang C, Zhu JB, Yan YY, Zhang W, Gong XJ, Wang X, Wang XL. Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p in vitro. Oncol Lett 2020;20:385. [PMID: 33154782 DOI: 10.3892/ol.2020.12248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wang D, Zhou Y, Hua L, Li J, Zhu N, Liu Y. CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients. IJGM 2022;Volume 15:2233-45. [DOI: 10.2147/ijgm.s349576] [Reference Citation Analysis]
21 Chen X, Gao K, Xiang Z, Zhang Y, Peng X. Identification and Validation of an Endoplasmic Reticulum Stress-Related lncRNA Signature for Colon Adenocarcinoma Patients. IJGM 2022;Volume 15:4303-19. [DOI: 10.2147/ijgm.s358775] [Reference Citation Analysis]
22 Ai L, Luo X, Yan X, Jiang S. MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2. Bioengineered 2021;12:4044-53. [PMID: 34288823 DOI: 10.1080/21655979.2021.1951930] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Müller D, Győrffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer 2022;:188722. [PMID: 35307512 DOI: 10.1016/j.bbcan.2022.188722] [Reference Citation Analysis]
24 Chang L, Yang P, Zhang C, Zhu J, Zhang Y, Wang Y, Ding J, Wang K. Long intergenic non-protein-coding RNA 467 promotes tumor progression and angiogenesis via the microRNA-128-3p/vascular endothelial growth factor C axis in colorectal cancer. Bioengineered 2022;13:12392-408. [PMID: 35587748 DOI: 10.1080/21655979.2022.2074666] [Reference Citation Analysis]
25 Rincón-riveros A, Rodríguez JA, Villegas VE, López-kleine L. Identification of Two Exosomal miRNAs in Circulating Blood of Cancer Patients by Using Integrative Transcriptome and Network Analysis. ncRNA 2022;8:33. [DOI: 10.3390/ncrna8030033] [Reference Citation Analysis]
26 Kudelova E, Holubekova V, Grendar M, Kolkova Z, Samec M, Vanova B, Mikolajcik P, Smolar M, Kudela E, Laca L, Lasabova Z. Circulating miRNA expression over the course of colorectal cancer treatment. Oncol Lett 2022;23:18. [PMID: 34868358 DOI: 10.3892/ol.2021.13136] [Reference Citation Analysis]
27 Reilly J, Kerkhof J, Sadikovic B. EpiSigns. Advances in Molecular Pathology 2020;3:29-39. [DOI: 10.1016/j.yamp.2020.07.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, Yang D, Li Q, Xu P, Hu R, Li X, Chen B, Wang J, Zen K, Li H, Davis MJ, Herold MJ, Pan HF, Jiang ZW, Huang DCS, Liu M, Ju J, Zhao Q. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med 2021;13:58. [PMID: 33853662 DOI: 10.1186/s13073-021-00871-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sun Z, Dang Q, Liu Z, Shao B, Chen C, Guo Y, Chen Z, Zhou Q, Hu S, Liu J, Yuan W. LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition. J Cancer 2021;12:3909-19. [PMID: 34093798 DOI: 10.7150/jca.55666] [Reference Citation Analysis]
30 Lam KK, Thean LF, Cheah PY. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention. Int J Biochem Cell Biol 2021;137:106032. [PMID: 34182137 DOI: 10.1016/j.biocel.2021.106032] [Reference Citation Analysis]
31 Appunni S, Rubens M, Ramamoorthy V, Tonse R, Saxena A, McGranaghan P, Kaiser A, Kotecha R. Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer. Front Nutr 2021;8:718389. [PMID: 34708063 DOI: 10.3389/fnut.2021.718389] [Reference Citation Analysis]
32 Zhan L, Zhang J, Zhu S, Liu X, Zhang J, Wang W, Fan Y, Sun S, Wei B, Cao Y. N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors. Front Cell Dev Biol 2021;9:736298. [PMID: 34616742 DOI: 10.3389/fcell.2021.736298] [Reference Citation Analysis]
33 Li L, Jiang K, Li D, Li D, Fan Z, Dai G, Tu S, Liu X, Wei G. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients. Front Oncol 2021;11:754221. [PMID: 34692540 DOI: 10.3389/fonc.2021.754221] [Reference Citation Analysis]
34 Wang H, Xing J, Wang W, Lv G, He H, Lu Y, Sun M, Chen H, Li X. Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. Front Cell Dev Biol 2020;8:601502. [PMID: 33644029 DOI: 10.3389/fcell.2020.601502] [Reference Citation Analysis]
35 Qin D, Guo Q, Wei R, Liu S, Zhu S, Zhang S, Min L. Predict Colon Cancer by Pairing Plasma miRNAs: Establishment of a Normalizer-Free, Cross-Platform Model. Front Oncol 2021;11:561763. [PMID: 33968711 DOI: 10.3389/fonc.2021.561763] [Reference Citation Analysis]
36 Sukocheva OA, Liu J, Neganova ME, Beeraka NM, Aleksandrova YR, Manogaran P, Grigorevskikh EM, Chubarev VN, Fan R. Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Semin Cancer Biol 2022:S1044-579X(22)00123-7. [PMID: 35623562 DOI: 10.1016/j.semcancer.2022.05.012] [Reference Citation Analysis]
37 Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875:188491. [PMID: 33316377 DOI: 10.1016/j.bbcan.2020.188491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
38 Roy S, Kanda M, Nomura S, Zhu Z, Toiyama Y, Taketomi A, Goldenring J, Baba H, Kodera Y, Goel A. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer. Mol Cancer 2022;21:42. [PMID: 35139874 DOI: 10.1186/s12943-022-01527-7] [Reference Citation Analysis]
39 Feng Z, Liu Z, Peng K, Wu W. A Prognostic Model Based on Nine DNA Methylation-Driven Genes Predicts Overall Survival for Colorectal Cancer. Front Genet 2022;12:779383. [DOI: 10.3389/fgene.2021.779383] [Reference Citation Analysis]
40 Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res 2021;151:425-68. [PMID: 34148620 DOI: 10.1016/bs.acr.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Tang Y, Tang R, Tang M, Huang P, Liao Z, Zhou J, Zhou L, Su M, Chen P, Jiang J, Hu Y, Zhou Y, Liao Q, Zeng Z, Xiong W, Chen J, Nie S. LncRNA DNAJC3-AS1 Regulates Fatty Acid Synthase via the EGFR Pathway to Promote the Progression of Colorectal Cancer. Front Oncol 2020;10:604534. [PMID: 33604287 DOI: 10.3389/fonc.2020.604534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zajkowska M, Mroczko B. Eotaxins and Their Receptor in Colorectal Cancer-A Literature Review. Cancers (Basel) 2020;12:E1383. [PMID: 32481530 DOI: 10.3390/cancers12061383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
43 Tu W, Gong J, Zhou Z, Tian D, Wang Z. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling. Cell Death Dis 2021;12:882. [PMID: 34580284 DOI: 10.1038/s41419-021-04166-w] [Reference Citation Analysis]
44 Mu L, Wang Y, Hu Y, Shi C, Alman BA, Zhang C, She J. The Role of TMIGD1 as a Tumor Suppressor in Colorectal Cancer. Genet Test Mol Biomarkers 2022;26:174-83. [PMID: 35481970 DOI: 10.1089/gtmb.2021.0169] [Reference Citation Analysis]
45 Ying HQ, Sun F, Liao YC, Cai D, Yang Y, Cheng XX. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer. Ther Adv Med Oncol 2021;13:17588359211022886. [PMID: 34262615 DOI: 10.1177/17588359211022886] [Reference Citation Analysis]
46 Knatko EV, Castro C, Higgins M, Zhang Y, Honda T, Henderson CJ, Wolf CR, Griffin JL, Dinkova-Kostova AT. Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer. Commun Biol 2021;4:1081. [PMID: 34526660 DOI: 10.1038/s42003-021-02552-w] [Reference Citation Analysis]
47 Almutairi BO, Almutairi MH, Alrefaei AF, Ali D, Alkahtani S, Alarifi S, Ahmad HI. Cigarette Smoke Regulates the Expression of EYA4 via Alternation of DNA Methylation Status. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/5032172] [Reference Citation Analysis]
48 Liu J, Qian J, Mo Q, Tang L, Xu Q. Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis. Bioengineered 2022;13:5407-20. [PMID: 35176937 DOI: 10.1080/21655979.2022.2037225] [Reference Citation Analysis]
49 Xie M, Yu T, Jing X, Ma L, Fan Y, Yang F, Ma P, Jiang H, Wu X, Shu Y, Xu T. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol Cancer 2020;19:112. [PMID: 32600329 DOI: 10.1186/s12943-020-01208-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 15.5] [Reference Citation Analysis]
50 Sobhani I, Rotkopf H, Khazaie K. Bacteria-related changes in host DNA methylation and the risk for CRC. Gut Microbes 2020;12:1800898. [PMID: 32931352 DOI: 10.1080/19490976.2020.1800898] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Masui K, Harachi M, K Cavenee W, S Mischel P, Shibata N. Codependency of Metabolism and Epigenetics Drives Cancer Progression: A Review. Acta Histochem Cytochem 2020;53:1-10. [PMID: 32201436 DOI: 10.1267/ahc.20002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
52 Sial N, Saeed S, Ahmad M, Hameed Y, Rehman A, Abbas M, Asif R, Ahmed H, Hussain MS, Rehman JU, Atif M, Khan MR. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer. Int J Gen Med 2021;14:7025-42. [PMID: 34707394 DOI: 10.2147/IJGM.S327367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Zhang S, Liu M, Yao Y, Yu B, Liu H. Targeting LSD1 for acute myeloid leukemia (AML) treatment. Pharmacol Res 2021;164:105335. [PMID: 33285227 DOI: 10.1016/j.phrs.2020.105335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Jiang Z, Hou Z, Liu W, Yu Z, Liang Z, Chen S. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance. Bioengineered 2022;13:810-23. [PMID: 34974791 DOI: 10.1080/21655979.2021.2012952] [Reference Citation Analysis]
55 Liu CG, Li J, Xu Y, Li W, Fang SX, Zhang Q, Xin HW, Ma Z. Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance. Mol Ther Oncolytics 2021;22:336-54. [PMID: 34553023 DOI: 10.1016/j.omto.2021.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
56 He X, Cheng G, Xiao F, Zhang L, Jin G, Zhao X, Liu Y, Liang J, Li Y, Liu Z, Yuan Q, Ren H, Wu Q, Wu J, Xue L, Feng J, Wang Z, Xing Y, Wu W, Li Z, Wei D, Song X. miR-4477b gene as a novel pathogenic mutation occurring during the transformation of colorectal adenoma into colorectal cancer. J Gastrointest Oncol 2021;12:69-78. [PMID: 33708425 DOI: 10.21037/jgo-20-600] [Reference Citation Analysis]
57 Schiroli D, Marraccini C, Zanetti E, Ragazzi M, Gianoncelli A, Quartieri E, Gasparini E, Iotti S, Baricchi R, Merolle L. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer. Diagnostics (Basel) 2021;11:727. [PMID: 33923883 DOI: 10.3390/diagnostics11040727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Rider CV, McHale CM, Webster TF, Lowe L, Goodson WH 3rd, La Merrill MA, Rice G, Zeise L, Zhang L, Smith MT. Using the Key Characteristics of Carcinogens to Develop Research on Chemical Mixtures and Cancer. Environ Health Perspect 2021;129:35003. [PMID: 33784186 DOI: 10.1289/EHP8525] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Aksan A, Farrag K, Aksan S, Schroeder O, Stein J. Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Front Immunol 2021;12:635899. [PMID: 33777027 DOI: 10.3389/fimmu.2021.635899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Pulverer W, Kruusmaa K, Schönthaler S, Huber J, Bitenc M, Bachleitner-Hofmann T, Bhangu JS, Oehler R, Egger G, Weinhäusel A. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value. Curr Issues Mol Biol 2021;43:1419-35. [PMID: 34698107 DOI: 10.3390/cimb43030100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wang X, Wang J, Wu J. Emerging roles for HMGA2 in colorectal cancer. Transl Oncol 2021;14:100894. [PMID: 33069103 DOI: 10.1016/j.tranon.2020.100894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Xiong J, Zhang L, Tang R, Zhu Z. MicroRNA-301b-3p facilitates cell proliferation and migration in colorectal cancer by targeting HOXB1. Bioengineered 2021;12:5839-49. [PMID: 34488545 DOI: 10.1080/21655979.2021.1962483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Panza A, Castellana S, Biscaglia G, Piepoli A, Parca L, Gentile A, Latiano A, Mazza T, Perri F, Andriulli A, Palmieri O. Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer. Int J Mol Sci 2020;21:E7120. [PMID: 32992457 DOI: 10.3390/ijms21197120] [Reference Citation Analysis]
65 Cao M, Zhang C, Zhou L. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma. Epigenomics 2021. [PMID: 34369810 DOI: 10.2217/epi-2021-0118] [Reference Citation Analysis]
66 Lin S, Gu S, Qian S, Liu Y, Sheng J, Li Q, Yang J, Ying X, Li Z, Tang M, Wang J, Chen K, Jin M. Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer. Front Oncol 2022;11:782077. [DOI: 10.3389/fonc.2021.782077] [Reference Citation Analysis]
67 Chen Y, Shao X, Zhao X, Ji Y, Liu X, Li P, Zhang M, Wang Q. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms. Biomed Pharmacother 2021;144:112252. [PMID: 34619493 DOI: 10.1016/j.biopha.2021.112252] [Reference Citation Analysis]
68 Almeida-Lousada H, Mestre A, Ramalhete S, Price AJ, de Mello RA, Marreiros AD, Neves RPD, Castelo-Branco P. Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers? Curr Oncol 2021;28:4874-93. [PMID: 34898591 DOI: 10.3390/curroncol28060411] [Reference Citation Analysis]
69 Jiang H, Yu Q, Chen X, Zhang C, Shen J, Shen M, Yang Y, Wang B, Pan B, Guo W. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients. J Clin Lab Anal 2021;35:e24030. [PMID: 34591323 DOI: 10.1002/jcla.24030] [Reference Citation Analysis]
70 Ng ZQ, Wijesuriya R, Misur P, Tan JH, Moe KS, Theophilus M. Opportunistic use of radiological measures of visceral adiposity for assessment of risk of colorectal adenoma. ANZ J Surg 2020;90:2298-303. [PMID: 32501646 DOI: 10.1111/ans.16063] [Reference Citation Analysis]
71 Yang M, Tao X, Scott K, Zhan Y, Scott RT, Seli E. Evaluation of genome-wide DNA methylation profile of human embryos with different developmental competences. Hum Reprod 2021;36:1682-90. [PMID: 33846747 DOI: 10.1093/humrep/deab074] [Reference Citation Analysis]
72 Ermine K, Yu J, Zhang L. Role of Receptor Interacting Protein (RIP) kinases in cancer. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.10.007] [Reference Citation Analysis]
73 Xu Y, Yu X, Zhang M, Zheng Q, Sun Z, He Y, Guo W. Promising Advances in LINC01116 Related to Cancer. Front Cell Dev Biol 2021;9:736927. [PMID: 34722518 DOI: 10.3389/fcell.2021.736927] [Reference Citation Analysis]
74 Duan W, Kong X, Li J, Li P, Zhao Y, Liu T, Binang HB, Wang Y, Du L, Wang C. LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway. Front Cell Dev Biol 2020;8:565355. [PMID: 33178684 DOI: 10.3389/fcell.2020.565355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Haebe JR, Bergin CJ, Sandouka T, Benoit YD. Emerging role of G9a in cancer stemness and promises as a therapeutic target. Oncogenesis 2021;10:76. [PMID: 34775469 DOI: 10.1038/s41389-021-00370-7] [Reference Citation Analysis]
76 Xu J, Chen J, Cheng C, Li H, Gao P, Zheng J, Wang J, Zhao D. Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/9952438] [Reference Citation Analysis]
77 Hanjani NA, Esmaelizad N, Zanganeh S, Gharavi AT, Heidarizadeh P, Radfar M, Omidi F, MacLoughlin R, Doroudian M. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Crit Rev Oncol Hematol 2021;169:103565. [PMID: 34871719 DOI: 10.1016/j.critrevonc.2021.103565] [Reference Citation Analysis]
78 Farhana A, Koh AE, Tong JB, Alsrhani A, Kumar Subbiah S, Mok PL. Nanoparticle-Encapsulated Camptothecin: Epigenetic Modulation in DNA Repair Mechanisms in Colon Cancer Cells. Molecules 2021;26:5414. [PMID: 34500845 DOI: 10.3390/molecules26175414] [Reference Citation Analysis]
79 Miao Y, Zhang H, Su B, Wang J, Quan W, Li Q, Mi D. Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer. PeerJ 2021;9:e11219. [PMID: 33868829 DOI: 10.7717/peerj.11219] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Das A, Hand TH, Smith CL, Wickline E, Zawrotny M, Li H. The molecular basis for recognition of 5'-NNNCC-3' PAM and its methylation state by Acidothermus cellulolyticus Cas9. Nat Commun 2020;11:6346. [PMID: 33311465 DOI: 10.1038/s41467-020-20204-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Andreuzzi E, Fejza A, Polano M, Poletto E, Camicia L, Carobolante G, Tarticchio G, Todaro F, Di Carlo E, Scarpa M, Scarpa M, Paulitti A, Capuano A, Canzonieri V, Maiero S, Fornasarig M, Cannizzaro R, Doliana R, Colombatti A, Spessotto P, Mongiat M. Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway. J Exp Clin Cancer Res 2022;41:60. [PMID: 35148799 DOI: 10.1186/s13046-022-02271-y] [Reference Citation Analysis]
82 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Reference Citation Analysis]
83 Basnet U, Patil AR, Kulkarni A, Roy S. Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective. Int J Environ Res Public Health 2021;18:5525. [PMID: 34063993 DOI: 10.3390/ijerph18115525] [Reference Citation Analysis]
84 Jing Z, Ziwang F, Yinhang W, Yani Z, Jian C, Jingwen W, Shuwen H. Novel acetylation-related gene signatures for predicting the prognosis of patients with colorectal cancer. Hum Cell 2022. [PMID: 35604486 DOI: 10.1007/s13577-022-00720-6] [Reference Citation Analysis]
85 Mauri G, Vitiello PP, Sogari A, Crisafulli G, Sartore-Bianchi A, Marsoni S, Siena S, Bardelli A. Liquid biopsies to monitor and direct cancer treatment in colorectal cancer. Br J Cancer 2022. [PMID: 35264786 DOI: 10.1038/s41416-022-01769-8] [Reference Citation Analysis]
86 Yang J, Chen W, Sun Y, Xia P, Liu J, Zhang W. The role of microRNAs in regulating cadmium-induced apoptosis by targeting Bcl-2 in IEC-6 cells. Toxicol Appl Pharmacol 2021;432:115737. [PMID: 34662668 DOI: 10.1016/j.taap.2021.115737] [Reference Citation Analysis]
87 Nait Slimane S, Marcel V, Fenouil T, Catez F, Saurin JC, Bouvet P, Diaz JJ, Mertani HC. Ribosome Biogenesis Alterations in Colorectal Cancer. Cells 2020;9:E2361. [PMID: 33120992 DOI: 10.3390/cells9112361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
88 Poggi A, Villa F, Fernadez JLC, Costa D, Zocchi MR, Benelli R. Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages. Cancers (Basel) 2021;13:3417. [PMID: 34298630 DOI: 10.3390/cancers13143417] [Reference Citation Analysis]
89 Huang Y, Wang P, Zhou W, Luo M, Xu Z, Cheng R, Xu C, Jin X, Li Y, Jiang Q. Comprehensive analysis of partial methylation domains in colorectal cancer based on single-cell methylation profiles. Brief Bioinform 2021:bbab267. [PMID: 34254994 DOI: 10.1093/bib/bbab267] [Reference Citation Analysis]
90 Rodriguez-Casanova A, Costa-Fraga N, Bao-Caamano A, López-López R, Muinelo-Romay L, Diaz-Lagares A. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer. Front Cell Dev Biol 2021;9:622459. [PMID: 33614651 DOI: 10.3389/fcell.2021.622459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
91 Bergin CJ, Zouggar A, Haebe JR, Masibag AN, Desrochers FM, Reilley SY, Agrawal G, Benoit YD. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer. Oncogene 2021;40:1191-202. [PMID: 33323965 DOI: 10.1038/s41388-020-01591-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
92 Zhou B, Zhang J, Zhu H, Wu S, Yuchi A. A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/1934381] [Reference Citation Analysis]
93 Sui J, Wu X, Wang C, Wang G, Li C, Zhao J, Zhang Y, Xiang J, Xu Y, Nian W, Cao F, Yu G, Lou Z, Hao L, Liu L, Li B, Zhang Z, Cai S, Liu H, Lan P, Zhang W. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study. Clin Epigenetics 2021;13:26. [PMID: 33536049 DOI: 10.1186/s13148-020-00985-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
94 De Angelis ML, Francescangeli F, Zeuner A, Baiocchi M. Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts. Cancers (Basel) 2021;13:5910. [PMID: 34885020 DOI: 10.3390/cancers13235910] [Reference Citation Analysis]
95 Amin A, Farrukh A, Murali C, Soleimani A, Praz F, Graziani G, Brim H, Ashktorab H. Saffron and Its Major Ingredients' Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability. Molecules 2021;26:3855. [PMID: 34202689 DOI: 10.3390/molecules26133855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Zhang Z, Tao Y, Hua Q, Cai J, Ye X, Li H. SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion. Biomed Res Int 2020;2020:8284576. [PMID: 33083486 DOI: 10.1155/2020/8284576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Liu Y, Xu L, Hao C, Wu J, Jia X, Ding X, Lin C, Zhu H, Zhang Y. Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer. Front Oncol 2022;12:866289. [DOI: 10.3389/fonc.2022.866289] [Reference Citation Analysis]
98 Kiweler N, Schwarz H, Nguyen A, Matschos S, Mullins C, Piée-staffa A, Brachetti C, Roos WP, Schneider G, Linnebacher M, Brenner W, Krämer OH. The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil. Cell Biol Toxicol. [DOI: 10.1007/s10565-022-09731-3] [Reference Citation Analysis]
99 Abi Zamer B, Abumustafa W, Hamad M, Maghazachi AA, Muhammad JS. Genetic Mutations and Non-Coding RNA-Based Epigenetic Alterations Mediating the Warburg Effect in Colorectal Carcinogenesis. Biology (Basel) 2021;10:847. [PMID: 34571724 DOI: 10.3390/biology10090847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Wu X, Li M, Li Y, Deng Y, Ke S, Li F, Wang Y, Zhou S. Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway. J Transl Med 2021;19:353. [PMID: 34404435 DOI: 10.1186/s12967-021-03018-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Mazouji O, Ouhajjou A, Incitti R, Mansour H. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance. Front Cell Dev Biol 2021;9:660924. [PMID: 34150757 DOI: 10.3389/fcell.2021.660924] [Reference Citation Analysis]
102 Zhang ML, Huang WJ, Yue CX, Li MM, Li N, Wang RT, Xie R. Significant difference of c-type lectin-like receptor 2 between colorectal cancer and polyp subgroups. Cancer Biomark 2021;31:99-105. [PMID: 33554888 DOI: 10.3233/CBM-200734] [Reference Citation Analysis]
103 Razi Soofiyani S, Ahangari H, Soleimanian A, Babaei G, Ghasemnejad T, Safavi SE, Eyvazi S, Tarhriz V. The role of circadian genes in the pathogenesis of colorectal cancer. Gene 2021;804:145894. [PMID: 34418469 DOI: 10.1016/j.gene.2021.145894] [Reference Citation Analysis]
104 Wang Y, Chen H, Wei X. Circ_0007142 downregulates miR-874-3p-mediated GDPD5 on colorectal cancer cells. Eur J Clin Invest 2021;51:e13541. [PMID: 33797091 DOI: 10.1111/eci.13541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F, Fagoonee S. The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells. Cancers (Basel) 2021;13:4092. [PMID: 34439247 DOI: 10.3390/cancers13164092] [Reference Citation Analysis]
106 Hudlikar R, Wang L, Wu R, Li S, Peter R, Shannar A, Chou PJ, Liu X, Liu Z, Kuo HD, Kong AN. Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates. Cancer Prev Res (Phila) 2021;14:151-64. [PMID: 33055265 DOI: 10.1158/1940-6207.CAPR-20-0217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
107 Moloudizargari M, Rahmani J, Asghari MH, Goel A. The prognostic role of miR-31 in colorectal cancer: the results of a meta-analysis of 4720 patients. Epigenomics 2022;14:101-12. [PMID: 34894715 DOI: 10.2217/epi-2021-0277] [Reference Citation Analysis]
108 Zheng QX, Wang J, Gu XY, Huang CH, Chen C, Hong M, Chen Z. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers. Biomed Pharmacother 2021;135:111169. [PMID: 33433359 DOI: 10.1016/j.biopha.2020.111169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
109 Shi C, Li S, Shen C, Pan F, Deng L, Fu W, Wang J, Zhang J. Icariside II suppressed tumorigenesis by epigenetically regulating the circβ-catenin-Wnt/β-catenin axis in colorectal cancer. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105800] [Reference Citation Analysis]
110 Liu C, Xu Y, Liu X, Fu Y, Zhu K, Niu Z, Liu J, Qian C. Upregulation of LINC00511 expression by DNA hypomethylation promotes the progression of breast cancer. Gland Surg 2021;10:1418-30. [PMID: 33968693 DOI: 10.21037/gs-21-84] [Reference Citation Analysis]
111 Chen K, Zeng Z, Ma C, Dang Y, Zhang H. Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers. Biosci Rep 2021;41:BSR20211096. [PMID: 34850851 DOI: 10.1042/BSR20211096] [Reference Citation Analysis]
112 Kan G, Wang Z, Sheng C, Chen G, Yao C, Mao Y, Chen S. Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells. Adv Sci (Weinh) 2021;8:2004344. [PMID: 34026451 DOI: 10.1002/advs.202004344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
113 Bergin CJ, Benoit YD. G9a Is SETting the Stage for Colorectal Oncogenesis. Genes (Basel) 2020;11:E616. [PMID: 32512705 DOI: 10.3390/genes11060616] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Wang Y, Zhu L, Guo M, Sun G, Zhou K, Pang W, Cao D, Tang X, Meng X. Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2. Cell Death Discov 2021;7:19. [PMID: 33469000 DOI: 10.1038/s41420-021-00402-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Huang Z, An R, Wei S, Wang J, Ye D. Noninvasive ratiometric fluorescence imaging of γ-glutamyltransferase activity using an activatable probe. Analyst 2021;146:1865-71. [PMID: 33480367 DOI: 10.1039/d0an02232b] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Jiang Z, Tai Q, Xie X, Hou Z, Liu W, Yu Z, Liang Z, Chen S. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway. J Exp Clin Cancer Res 2021;40:227. [PMID: 34253241 DOI: 10.1186/s13046-021-02029-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Khan AA. Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence? J Cancer Res Clin Oncol 2021;147:2199-207. [PMID: 34115239 DOI: 10.1007/s00432-021-03685-5] [Reference Citation Analysis]
118 Li M, Sun X, Yao H, Chen W, Zhang F, Gao S, Zou X, Chen J, Qiu S, Wei H, Hu Z, Chen W. Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients. Toxicol Appl Pharmacol 2021;427:115657. [PMID: 34332992 DOI: 10.1016/j.taap.2021.115657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Wu Y, Yang X, Jiang G, Zhang H, Ge L, Chen F, Li J, Liu H, Wang H. 5'-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome Med 2021;13:20. [PMID: 33563322 DOI: 10.1186/s13073-021-00833-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Wang M, Ibeagha-Awemu EM. Impacts of Epigenetic Processes on the Health and Productivity of Livestock. Front Genet 2020;11:613636. [PMID: 33708235 DOI: 10.3389/fgene.2020.613636] [Reference Citation Analysis]
121 Wu S, Zhou Y, Liu P, Zhang H, Wang W, Fang Y, Shen X. MicroRNA-29b-3p promotes 5-fluorouracil resistance <em>via</em> suppressing TRAF5-mediated necroptosis in human colorectal cancer. Eur J Histochem 2021;65. [PMID: 34155879 DOI: 10.4081/ejh.2021.3247] [Reference Citation Analysis]
122 Yang F, Xuan G, Chen Y, Cao L, Zhao M, Wang C, Chen E. MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer. Front Cell Dev Biol 2022;10:828128. [DOI: 10.3389/fcell.2022.828128] [Reference Citation Analysis]
123 Gutierrez A, Demond H, Brebi P, Ili CG. Novel Methylation Biomarkers for Colorectal Cancer Prognosis. Biomolecules 2021;11:1722. [PMID: 34827720 DOI: 10.3390/biom11111722] [Reference Citation Analysis]
124 Yang T, Yang Y, Wang Y. Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy. Clin Epigenetics 2021;13:113. [PMID: 34001246 DOI: 10.1186/s13148-021-01098-2] [Reference Citation Analysis]
125 Hu S, Yin J, Yan S, Hu P, Huang J, Zhang G, Wang F, Tong Q, Zhang Y. Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K/AKT/mTOR pathways. Bioorg Chem 2021;109:104693. [PMID: 33609914 DOI: 10.1016/j.bioorg.2021.104693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Ibrahiem AT, Fawzy MS, Abu AlSel BT, Toraih EA. Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study. J Clin Lab Anal 2021;35:e23679. [PMID: 33296098 DOI: 10.1002/jcla.23679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Hussain S, Tulsyan S, Dar SA, Sisodiya S, Abiha U, Kumar R, Mishra BN, Haque S. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00193-0. [PMID: 34182144 DOI: 10.1016/j.semcancer.2021.06.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Zhang X, Dong Z, Cui H. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer. Biomolecules 2021;11:1406. [PMID: 34680038 DOI: 10.3390/biom11101406] [Reference Citation Analysis]
129 Tan S, Gui W, Wang S, Sun C, Xu X, Liu L. A methylation-based prognostic model predicts survival in patients with colorectal cancer. J Gastrointest Oncol 2021;12:1590-600. [PMID: 34532113 DOI: 10.21037/jgo-21-376] [Reference Citation Analysis]
130 Park YL, Park SY, Oh HH, Chung MW, Hong JY, Kim KH, Myung DS, Cho SB, Lee WS, Kim HS, Joo YE. A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer. Cancers (Basel) 2021;13:1927. [PMID: 33923541 DOI: 10.3390/cancers13081927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Liu A, Zhou K, Martínez MA, Lopez-Torres B, Martínez M, Martínez-Larrañaga MR, Wang X, Anadón A, Ares I. A "Janus" face of the RASSF4 signal in cell fate. J Cell Physiol 2021. [PMID: 34553373 DOI: 10.1002/jcp.30592] [Reference Citation Analysis]
132 Luo Z, Fu Z, Li T, Zhang Y, Zhang J, Yang Y, Yang Z, Li Q, Qiu Z, Huang C. Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer. Front Oncol 2021;11:709835. [PMID: 34790565 DOI: 10.3389/fonc.2021.709835] [Reference Citation Analysis]
133 Xu C, Guo X, Zhou C, Zhang H. Brucea javanica oil emulsion injection (BJOEI) as an adjunctive therapy for patients with advanced colorectal carcinoma: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21155. [PMID: 32629751 DOI: 10.1097/MD.0000000000021155] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Zhu Y, Wei W, Zhang Y, Wu J, Ma R, Feng J. Role of ATP5B in colorectal cancer. Precision Medical Sciences 2021;10:21-5. [DOI: 10.1002/prm2.12030] [Reference Citation Analysis]
135 Zou Q, Wang X, Ren D, Hu B, Tang G, Zhang Y, Huang M, Pai RK, Buchanan DD, Win AK, Newcomb PA, Grady WM, Yu H, Luo Y. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer. J Immunother Cancer 2021;9:e002671. [PMID: 34548385 DOI: 10.1136/jitc-2021-002671] [Reference Citation Analysis]
136 Goel A. The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay Goel. Epigenomics 2022. [PMID: 35081730 DOI: 10.2217/epi-2022-0010] [Reference Citation Analysis]
137 Zheng L, Zhan Y, Lu J, Hu J, Kong D. A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer. Ann Transl Med 2021;9:680. [PMID: 33987378 DOI: 10.21037/atm-21-1010] [Reference Citation Analysis]
138 Jiang D, Xie X, Lu Z, Liu L, Qu Y, Wu S, Li Y, Li G, Wang H, Xu G. Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics. Front Genet 2020;11:560186. [PMID: 33193642 DOI: 10.3389/fgene.2020.560186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
139 Zhang JY, Wu XW, Wang X, Wang R, Liu WT. Can combination of CEA, CA 19-9, and CA242 improve diagnostic sensitivity and diagnostic value for colorectal cancer? A Meta-analysis. Shijie Huaren Xiaohua Zazhi 2021; 29(14): 825-834 [DOI: 10.11569/wcjd.v29.i14.825] [Reference Citation Analysis]
140 Yoshikawa T, Fukuda A, Omatsu M, Namikawa M, Sono M, Fukunaga Y, Masuda T, Araki O, Nagao M, Ogawa S, Masuo K, Goto N, Hiramatsu Y, Muta Y, Tsuda M, Maruno T, Nakanishi Y, Kawada K, Takaishi S, Seno H. Brg1 is required to maintain colorectal cancer stem cells. J Pathol 2021;255:257-69. [PMID: 34415580 DOI: 10.1002/path.5759] [Reference Citation Analysis]
141 Guo X, Song C, Fang L, Li M, Yue L, Sun Q. FLRT2 functions as Tumor Suppressor gene inactivated by promoter methylation in Colorectal Cancer. J Cancer 2020;11:7329-38. [PMID: 33193897 DOI: 10.7150/jca.47558] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Fritz J, Lefebvre O, Fernandez A, Schmidt J, Bagnard D. Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression. Cancers (Basel) 2020;12:E149. [PMID: 31936310 DOI: 10.3390/cancers12010149] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Chen M, Li S, Liang Y, Zhang Y, Luo D, Wang W. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer. Front Oncol 2021;11:656509. [PMID: 34178642 DOI: 10.3389/fonc.2021.656509] [Reference Citation Analysis]
144 Oryani MA, Tavasoli A, Ghalavand MA, Ashtiani RZ, Rezaee A, Mahmoudi R, Golvari H, Owrangi S, Soleymani-Goloujeh M. Epigenetics and its therapeutic potential in colorectal cancer. Epigenomics 2022. [PMID: 35473313 DOI: 10.2217/epi-2022-0067] [Reference Citation Analysis]
145 Hasan NM, Sharma A, Ruzgar NM, Deshpande H, Olino K, Khan S, Ahuja N. Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma. Oncotarget 2021;12:1566-79. [PMID: 34381562 DOI: 10.18632/oncotarget.28032] [Reference Citation Analysis]
146 Liu F, Dai Z, Cheng Q, Xu L, Huang L, Liu Z, Li X, Wang N, Wang G, Wang L, Wang Z. LncRNA-targeting bio-scaffold mediates triple immune effects for postoperative colorectal cancer immunotherapy. Biomaterials 2022;284:121485. [DOI: 10.1016/j.biomaterials.2022.121485] [Reference Citation Analysis]
147 Ruiz-Bañobre J, Goel A. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Adv Cancer Res 2021;151:231-304. [PMID: 34148615 DOI: 10.1016/bs.acr.2021.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
148 Liu Z, Gu Y, Li X, Zhou L, Cheng X, Jiang H, Huang Y, Zhang Y, Xu T, Yang W, Huang Q. Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2. Dig Dis Sci 2021. [PMID: 33982216 DOI: 10.1007/s10620-021-07004-3] [Reference Citation Analysis]
149 Liu R, Deng P, Zhang Y, Wang Y, Peng C. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway. World J Surg Oncol 2021;19:51. [PMID: 33596920 DOI: 10.1186/s12957-021-02164-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
150 Seely KD, Morgan AD, Hagenstein LD, Florey GM, Small JM. Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia. Cancers 2022;14:1019. [DOI: 10.3390/cancers14041019] [Reference Citation Analysis]
151 Xiang Q, Zhao Y, Lin J, Jiang S, Li W. Epigenetic modifications in spinal ligament aging. Ageing Res Rev 2022;77:101598. [PMID: 35218968 DOI: 10.1016/j.arr.2022.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Nishiwada S, Sho M, Banwait JK, Yamamura K, Akahori T, Nakamura K, Baba H, Goel A. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases. Gastroenterology 2020;159:562-74. [PMID: 32376411 DOI: 10.1053/j.gastro.2020.04.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
153 Tong Y, Huang Y, Zhang Y, Zeng X, Yan M, Xia Z, Lai D. DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration. Cell Death Dis 2021;12:529. [PMID: 34023852 DOI: 10.1038/s41419-021-03796-4] [Reference Citation Analysis]
154 Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. [DOI: 10.1038/s41416-021-01672-8] [Reference Citation Analysis]
155 Codrich M, Dalla E, Mio C, Antoniali G, Malfatti MC, Marzinotto S, Pierobon M, Baldelli E, Di Loreto C, Damante G, Terrosu G, Pucillo CEM, Tell G. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN. J Exp Clin Cancer Res 2021;40:198. [PMID: 34154611 DOI: 10.1186/s13046-021-01986-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 Xie JB, Pang YS, Li X, Wu XT. Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients. World J Clin Cases 2021; 9(15): 3531-3545 [PMID: 34046453 DOI: 10.12998/wjcc.v9.i15.3531] [Reference Citation Analysis]
157 Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B, Shen C, Ma Y, Jiang S, Ma D, Tong T, Zhang X, Gao Z, Zhu X, Fang J, Chen H, Hong J. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p. Gastroenterology 2021:S0016-5085(21)03341-2. [PMID: 34371001 DOI: 10.1053/j.gastro.2021.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Du T, Yi S, Wang Y, Zhao Q, Ma P, Jiang W. Circular RNA_0120376 regulates microRNA-148b-3 and centrosomal protein 55 to promote non-small cell lung cancer development. Bioengineered 2022;13:11844-55. [PMID: 35549631 DOI: 10.1080/21655979.2022.2052647] [Reference Citation Analysis]
159 Hernandez-Meza G, von Felden J, Gonzalez-Kozlova EE, Garcia-Lezana T, Peix J, Portela A, Craig AJ, Sayols S, Schwartz M, Losic B, Mazzaferro V, Esteller M, Llovet JM, Villanueva A. DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology 2021;74:183-99. [PMID: 33237575 DOI: 10.1002/hep.31659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
160 Bazzocco S, Dopeso H, Martínez-Barriocanal Á, Anguita E, Nieto R, Li J, García-Vidal E, Maggio V, Rodrigues P, de Marcondes PG, Schwartz S Jr, Aaltonen LA, Sánchez A, Mariadason JM, Arango D. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis. Clin Epigenetics 2021;13:88. [PMID: 33892786 DOI: 10.1186/s13148-021-01070-0] [Reference Citation Analysis]
161 Shen HY, Li XQ, Fan WQ, Wang YW, Huang F, Wu JQ, Zhang W, Feng XS, Chao X. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC). Eur J Pharmacol 2021;909:174405. [PMID: 34384755 DOI: 10.1016/j.ejphar.2021.174405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Otero-Estévez O, Gallardo-Gomez M, Cadena MP, Rodríguez-Berrocal FJ, Cubiella J, Ramirez VH, García-Nimo L, Chiara L. Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer. Diagnostics (Basel) 2020;10:E437. [PMID: 32605302 DOI: 10.3390/diagnostics10070437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
163 Gu J, Dong L, Wang Y, Nie W, Liu W, Zhao JA. LINC01224 promotes colorectal cancer progression through targeting miR-485-5p/MYO6 axis. World J Surg Oncol 2021;19:281. [PMID: 34535152 DOI: 10.1186/s12957-021-02389-x] [Reference Citation Analysis]
164 Liu J, Zhan Y, Wang J, Wang J, Guo J, Kong D. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis. Mol Oncol 2020;14:3211-33. [PMID: 33040438 DOI: 10.1002/1878-0261.12819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
165 Cai Z, Suo L, Huang Z. Isoflurane Suppresses Proliferation, Migration, and Invasion and Facilitates Apoptosis in Colorectal Cancer Cells Through Targeting miR-216. Front Med (Lausanne) 2021;8:658926. [PMID: 34458282 DOI: 10.3389/fmed.2021.658926] [Reference Citation Analysis]